Market Overview

Morning Market Movers

Share:
Related RPRX
Repros Therapeutics Shares Rally Following Ladenburg Upgrade To Buy, Positive Data
Benzinga's Top Upgrades
FDA Ad Comm backs expanded criteria for drug to show clinical benefit of treatments for secondary hypogonadism (Seeking Alpha)
Related KYTH
Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA
Benzinga's Top Downgrades

Repros Therapeutics (NASDAQ: RPRX) moved up 26.15% to $26.82 after the company announced topline results from both the second pivotal efficacy study as well as the 6 month safety study of Androxal®.

Kythera Biopharmaceuticals (NASDAQ: KYTH) jumped 24.43% to $41.72 after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat.

Agenus (NASDAQ: AGEN) rose 22.99% to $3.37 after the company reported positive follow-on Phase 2 results for brain cancer vaccine.

Aeropostale (NYSE: ARO) shares jumped 18.23% to $10.18 after private equity firm Sycamore Partners bought a 7.96% stake in the company.

Posted-In: Morning Market MoversNews Intraday Update Markets Movers

 

Related Articles (AGEN + ARO)

View Comments and Join the Discussion!